Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M200009200 on April 16, 2002

J. Biol. Chem., Vol. 277, Issue 27, 24490-24498, July 5, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/27/24490    most recent
M200009200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vickrey, J. F.
Right arrow Articles by Evans, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vickrey, J. F.
Right arrow Articles by Evans, D. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Pseudomonas aeruginosa Aspartate Transcarbamoylase

CHARACTERIZATION OF ITS CATALYTIC AND REGULATORY PROPERTIES*

John F. VickreyDagger , Guy Hervé§, and David R. EvansDagger

From the Dagger  Department of Biochemistry and Molecular Biology, Wayne State University School of Medicine, Detroit, Michiagan 48201 and the § Laboratoire de Biochimie des Signaux Régulateurs Cellulaires et Moléculaires, UMR CNRS 7631, Université Pierre et Marie Curie, 96 Bd. Raspail, 75006 Paris, France

Received for publication, January 2, 2002, and in revised form, March 13, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Aspartate transcarbamoylase from Pseudomonadaceae is a class A enzyme consisting of six copies of a 36-kDa catalytic chain and six copies of a 45-kDa polypeptide of unknown function. The 45-kDa polypeptide is homologous to dihydroorotase but lacks catalytic activity. Pseudomonas aeruginosa aspartate transcarbamoylase was overexpressed in Escherichia coli. The homogeneous His-tagged protein isolated in high yield, 30 mg/liter of culture, by affinity chromatography and crystallized. Attempts to dissociate the catalytic and pseudo-dihydroorotase (pDHO) subunits or to express catalytic subunits only were unsuccessful suggesting that the pDHO subunits are required for the proper folding and assembly of the complex. As reported previously, the enzyme was inhibited by micromolar concentrations of all nucleotide triphosphates. In the absence of effectors, the aspartate saturation curves were hyperbolic but became strongly sigmoidal in the presence of low concentrations of nucleotide triphosphates. The inhibition was unusual in that only free ATP, not MgATP, inhibits the enzyme. Moreover, kinetic and binding studies with a fluorescent ATP analog suggested that ATP induces a conformational change that interferes with the binding of carbamoyl phosphate but has little effect once carbamoyl phosphate is bound. The peculiar allosteric properties suggest that the enzyme may be a potential target for novel chemotherapeutic agents designed to combat Pseudomonas infection.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Pseudomonadaceae is a family of eubacteria with a wide ecological distribution that is pathogenic in animals (1, 2). Pseudomonas aeruginosa, the principle cause of morbidity and mortality in immunocompromised patients and burn victims (3-5), is an obligate pathogen. In cystic fibrosis, P. aeruginosa infection is the usual cause of death. In the design of therapeutic strategies, comparatively little attention has focused on the physiology of the organism itself, despite the unusual metabolism exhibited by Pseudomonadaceae such as uracil catabolism (6), the lack of gene repression (7, 8), and the ability to use arginine as the sole source of carbon, nitrogen, and energy (9, 10).

In other organisms, studies of de novo pyrimidine biosynthesis and salvage are actively pursued because of the relationship of these pathways to growth, development, and chemotherapy. Aspartate transcarbamoylase (ATCase,1 EC 2.1.3.2) catalyzes the formation of carbamoyl aspartate from carbamoyl phosphate and aspartate (11) in the de novo biosynthetic pathway. The structure and function of the enzyme from Escherichia coli has been extensively studied and has become the prototype of allosteric enzymes. However, ATCases are highly polymorphic differing both in structure and mode of regulation. Jones and co-workers (12) identified three distinct classes of bacterial aspartate transcarbamoylase.

E. coli ATCase, designated a class B enzyme, consists of six copies of two types of polypeptide chains, catalytic and regulatory. The 34-kDa catalytic chains associate to form catalytically active but unregulated trimers. The 17-kDa regulatory chains form dimeric subunits that bind the allosteric effectors CTP, ATP, and UTP but have no activity. Crystallographic studies (13-16) have shown that the holoenzyme is a 32 dodecamer consisting of two catalytic subunits and three regulatory subunits. The allosteric effectors bind to a common site on each regulatory chain and transmit allosteric signals to the active site located 60 Å away on the catalytic subunit. In addition to E. coli, class B ATCases are found in other members of the family Enterobacteriaceae such as Salmonella typhimurium, Erwinia herbicola, Serratia marcescens (17), and in some hyperthermophilic archeae such as Pyrococcus abyssi (18). The class B ATCases differ in sensitivity to allosteric effectors but have the same structural organization.

The class C enzymes are much smaller, 100 kDa, and lack separate regulatory subunits. Barbson and Switzer (19) characterized the first class C ATCase from Bacillus subtilis. The enzyme was shown to be an unregulated trimer consisting of three 34-kDa catalytic chains. When the enzyme was cloned and sequenced, it was found (20) to be homologous to the E. coli ATCase catalytic chain, and subsequent x-ray studies (21) showed that it has a very similar tertiary structure.

The class A ATCases are the largest and least well understood. Early studies of Pseudomonas fluorescens ATCase (22) suggested that the molecule was dimeric; however, it was subsequently shown (23, 24) to be a dodecamer consisting of six copies of a 36-kDa catalytic chain and 45-kDa polypeptide of unknown function. When O'Donovan and associates (25, 45) cloned and sequenced the genes encoding the enzyme from Pseudomonas putida and P. aeruginosa, the surprising discovery was that, although the 36-kDa chains were clearly homologous to the catalytic chains of other well characterized ATCases, the sequence of the 45-kDa polypeptide closely resembled dihydroorotase, the enzyme that catalyzes the subsequent step in the de novo pyrimidine biosynthetic pathway. However, the enzyme complex lacks dihydroorotase activity, so the 45-kDa polypeptide has been designated a pseudo-DHOase, analogous to the homologous inactive domain found (26) in the yeast multifunctional protein encoded by the ura2 locus.

The regulation of the Pseudomonas enzyme is also unusual. In E. coli the flux of metabolites through the de novo pyrimidine biosynthesis is controlled by the allosteric regulation of ATCase. ATP activates the enzyme whereas CTP and UTP function as feedback inhibitors. The reciprocal regulation of the enzyme by these allosteric effectors is thought to prevent the accumulation of pyrimidines and to maintain a balance in the intracellular pools of purines and pyrimidines. In contrast, Pseudomonas ATCase (22, 23) is inhibited by low concentrations of all of the nucleotide triphosphates. Although there is precedent in that the enzymes from several other bacterial species are inhibited by a broad spectrum of pyrimidines and purines (27), the rationale for this type of allosteric control of de novo pyrimidine biosynthesis has been elusive.

Mechanistic and structural studies of Pseudomonadaceae aspartate transcarbamoylase have been hampered by the difficulty in isolating sufficient quantities of the protein and by its intrinsic instability. This report describes the overexpression, purification, and characterization of P. aeruginosa ATCase. The extreme sensitivity of the purified recombinant protein to nucleotide triphosphates was confirmed, but the regulation was found to be unusual in several respects.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Strains and Plasmids-- The plasmid, pA10, that encodes both the subunits of P. aeruginosa ATCase was obtained (45; GenBankTM accession number L19649) by inserting a 3.5-kb XhoI fragment of the cosmid 011125 that complemented ATCase-deficient E. coli strains into the SalI site of pUC18. The expression vector pRSETC was purchased from Invitrogen. Host E. coli cells were either EK1104 (F-, ara, thi, Delta pro-lac, Delta pyrB, pyrF±, rpsL) (28), BL21 (DE3) (F- dcm ompT hsdS(rB-mB-) gal lambda (DE3)), or DH5alpha (F- (phi 80d lacZDelta M15) d(lacZYA-argF)U169 endA1 recA1 hsdR17(rK-mK+)deoR thi-1 supE44 gyrA96 relA1 lambda -). Routine genetic manipulations were carried out using the strain DH5a.

Protein and DNA Methods-- Restriction digests, ligations, and other DNA methods were carried out using standard protocols (29). Protein concentration was determined by the Lowry method (30) using bovine serum albumin as the standard. SDS-gel electrophoresis was carried out on 12% polyacrylamide gels (31). In some instances, 6% non-denaturing polyacrylamide gels were run, and the ATCase activity of the bands in the gel was determined as described previously (18).

Enzyme Assays-- Aspartate transcarbamoylase assay was assayed by the method of Prescott and Jones (12) as modified by Pastra-Landis et al. (32). Typically 50 ng of the purified protein was assayed at 37 °C for 20 min in a 1.0-ml assay mixture consisting of 5 mM carbamoyl phosphate and 20 mM aspartate in 50 mM Tris-HCl, pH 8.5. Alternatively, a radioactive assay described previously (33) that uses [14C]aspartate as a substrate was used to measure aspartate transcarbamoylase activity. Unless specifically noted, the reaction was initiated by the addition of carbamoyl phosphate to the otherwise complete assay mixture. A unit of enzyme activity is defined as µmol/h/mg.

To determine whether inhibition by two nucleotides is additive, antagonistic, or synergistic, the extent of inhibition was determined in the presence of one and both effectors following the approach described by Webb (34). The activity in the presence of an inhibitor 1 is given by the expression a1 = (1 - i1), where i is the fractional inhibition. In the presence of two inhibitors that function independently, inhibition should be additive, and the activity (a12) would be the product of the activities or a12 = (1 - i1)(1 - i2) = i1 + i2 - i1i2. Smaller and larger values of a12 would be indicative of antagonist or synergistic inhibition, respectively. Additive or synergistic inhibition is an indication that the inhibitors bind to different sites on the enzyme. For these experiments, one inhibitor was held constant at a concentration giving ~50% inhibition, whereas the second was varied over it effective range.

The pH activity profile was determined using a three-part buffer (35) consisting of 0.05 M MES, 0.1 M diethanolamine, and 0.05 M N-ethylmorpholine. A least squares fit of the substrate saturation data to the Michaelis-Menten or Hill equation was carried out using either Kaleidagraph 2.1 (Abelbeck software) or Scientist (Micromath). The concentration of free ATP was calculated from the total concentration of ATP and Mg2+ ion using published (36) stability constants.

Cell Growth and Induction-- P. aeruginosa ATCase is expressed constitutively in EK1104 cells transformed with pA10 grown in M9 media supplemented with 0.4% glucose, 0.1% casamino acids, 0.5 µg/ml ZnSO4·7H2O, 0.1 mM CaCl2, 0.5 µg/ml FeSO4·7H2O, 1 mM MgSO47H2O, 5 µg/ml thiamin, 0.001% tryptophan. Alternatively, the recombinant protein was obtained from BL21(DE3) E. coli cells transformed with pJV34, a plasmid constructed as described under "Results." The competent host cells were prepared using the method of Huff et al. (37). The expression of the enzyme in the pJV34 transformants was under control of the T7 promoter. A 1-ml culture of exponentially growing transformed cells obtained from a single colony was used to inoculate 100 ml of YT media supplemented with 100 µg/ml ampicillin. The cells were grown at 37 °C in a rotary shaker (225 rpm) at 37 °C to an absorbance of 0.4-0.6. The expression of the protein was then induced by the addition of IPTG to a concentration of 400 µM. The cells were then grown for an additional 2 h prior to harvesting.

Purification of the Recombinant Proteins-- For purification of the recombinant protein from EK1104 cells transformed with pA10, 85 g of packed cells were suspended in 100 ml of sonication buffer, 50 mM Tris, pH 8.5, 2 mM 2-mercaptoethanol, and 0.02 mM ZnCl2 at 4 °C. The suspension was sonicated on ice and then centrifuged for 15 min at 31,000 × g to remove the cellular debris. After clarifying the extract by centrifugation at 48,000 × g for 90 min, the supernatant (128 ml) was fractionated with ammonium sulfate. Protein precipitating between 30 and 45% ammonium sulfate saturation was resuspended in 6 ml of the sonication buffer and dialyzed exhaustively against the same buffer. The dialyzed protein was chromatographed on a 26 × 1.6-cm Sepharose Q fast-flow column equilibrated in 50 mM Tris-HCl, pH 8.5, at a flow rate 1.0 ml/min. After washing the column overnight with 50 ml of 0.25 M NaCl in 50 mM Tris-HCl, pH 8.5, the protein was eluted with a linear gradient of 0.25-0.6 M NaCl in the same buffer. Fractions containing ATCase activity were pooled, and glycerol was added to a final concentration of 10%. The preparation was concentrated using an Amicon Protein Concentrator under nitrogen to a final volume of 20 ml. The concentrated sample was chromatographed on a 1.9 × 90-cm Sephacryl 300HR column equilibrated and eluted with 50 mM Tris-HCl, pH 8.5, 10% glycerol at a flow rate of 12 ml/h. The active fractions were then applied to a 6 × 1.2-cm hydroxylapatite column and eluted with a 0-0.2 M gradient of potassium phosphate in the same buffer.

For purification of recombinant ATCase from pJV34 BL21(DE3) transformants, 500 mg of packed cells obtained from a 100-ml culture were washed once with 2 ml of 50 mM Tris-HCl, pH 8.5, 10% glycerol containing 200 mM NaCl and resuspended in 2 ml of the same buffer. The cells were disrupted using a Branson sonifier. The sonication protocol consisted of four 20-s bursts with a microtip set at 50% duty cycle, output 5.5, with a 1-min cooling period on ice between each burst. The cellular debris was removed by centrifugation 12,000 × g for 4 min. The supernatant was immediately applied to 1 ml of ProBondTM nickel matrix (Invitrogen) that had been equilibrated with 50 mM Tris-HCl, pH 8.5, 10% glycerol, 200 mM NaCl. The column was successively washed with 2 ml of 25 mM imidazole, 2 ml of 50 mM imidazole, and 2 ml of 200 mM imidazole in the same buffer. The fractions containing ATCase were pooled and dialyzed against 50 mM Tris-HCl, pH 8.5, 10% glycerol at 4 °C and then stored at -80 °C.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Expression and Purification of P. aeruginosa ATCase-- Initially, recombinant P. aeruginosa ATCase was isolated from E. coli transformed with the plasmid pA10 following the five-step protocol described under "Experimental Procedures." The final yield (Table I) starting with 85 g of packed cells was 400 µg. The specific activity of 525 µmol/h/mg of the homogeneous protein was appreciably lower than the values observed for ATCase isolated from other bacterial sources.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Purification of recombinant P. aeruginosa ATCase

Because of the low specific enzymatic activity, the low yield of protein, and the laborious isolation procedure, the protein was recloned into a high expression system that appends a His tag affinity label to the amino end of the catalytic subunit to facilitate purification. The 2.4-kb PstI fragment of pA10 containing the entire P. aeruginosa ATCase coding sequence was inserted (Fig. 1) into the expression vector pRSETC. The resulting plasmid, pJV34, encodes the 45-kDa pDHO subunit and the 36-kDa catalytic subunit with a 3-kDa chain segment containing six histidines fused to the amino end. Following transformation into E. coli strain BL21(DE3), expression of the recombinant protein was induced with IPTG. P. aeruginosa ATCase was produced at very high levels (Fig. 2, lane Ex), but approximately two-thirds of the protein was recovered in the pellet following low speed centrifugation. The ATCase in the supernatant fraction (Fig. 2, lane Su) was purified in a single step by chromatography on a Ni2+ affinity column. After washing the column to remove non-specifically bound proteins, the ATCase was eluted with 200 mM imidazole as a homogeneous protein (Fig. 2, lane ATC) consisting of 45- and 36-kDa polypeptides. Electrophoresis on non-denaturing polyacrylamide gels revealed a single species that migrated appreciably more slowly than E. coli ATCase (data not shown), a result consistent with the dodecameric structure (23) of the Pseudomonas enzyme. A yield (Table I) of 3 mg of homogeneous protein was obtained from a 100-ml culture (0.5 g of packed cells). The final specific activity of the purified ATCase was 12,500 µmol/h/mg, comparable with that observed (28) for the E. coli enzyme. The histidine-rich segment at the amino end of the catalytic chain could be removed by enterokinase protease digestion. The cleaved catalytic chain was the same size as the wild type enzyme, but the first 8 residues at the amino end differed in sequence (Fig. 1) as a consequence of the cloning procedure. The specific activity of the ATCase isolated using the pJV34 expression system was 51-fold higher that the recombinant protein isolated from the pA10 transformants.


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 1.   Cloning and expression of P. aeruginosa ATCase. The plasmid pA10 (45) was constructed by inserting a 3.5-kb XhoI fragment of the cosmid 011125 into the SalI site of pUC18 and produced low levels of functional P. aeruginosa ATCase. To increase the level of expression, pA10 was digested with PstI, and the 2.4-kbp fragment was inserted into the PstI site in the polycloning region of the vector pRSETC. In this system, expression is under control of the T7 promoter. Transformation of the resulting plasmid pJV34 into E. coli BL21(DE3) and induction with IPTG resulted in the expression of high levels of the P. aeruginosa enzyme. The catalytic chain has a 38-residue chain segment containing six consecutive histidine residues and enterokinase cleavage site fused to the amino end of the polypeptide. The first 8 residues of the native catalytic chain are replaced by 8 residues from the fusion peptide.


View larger version (80K):
[in this window]
[in a new window]
 
Fig. 2.   Expression and purification of P. aeruginosa ATCase. A, the pJV34/E. coli BL21(DE3) transformants produced high levels of P. aeruginosa ATCase representing 70% of the total protein in the cell extract (Ex). The soluble fraction (Su), obtained by centrifugation at 12,000 × g for 4 min, was applied to a 1.0-ml Ni2+ affinity column. The column was washed with 3 column volumes (E1, E2, and E3) of 50 mM Tris-HCl, pH 8.5, 10% glycerol, 200 mM NaCl, and 25 mM imidazole. The purified protein (ATC) was eluted with the same buffer except that the concentration of imidazole was increased to 200 mM. Molecular weight standards (St) are also shown, as is a more concentrated sample of the protein (ATC) on the adjacent gel. B, purified ATCase, at a final concentration of 1 mg/ml, was crystallized by the hanging drop method in 0.1 M citrate, pH 5.0, 10% 6K polyethylene glycol. The crystals, thick trapezoidal plates, grew to 0.2-mm in the longest dimension within 1 week.

The purified protein was crystallized by the hanging drop method (38). Equal volumes (2 µl) of the purified protein at a concentration of 1 mg/ml in 50 mM Tris-HCl, pH 8.5, was mixed with the precipitin, 100 mM citrate, pH 5, and 10% 6K polyethylene glycol. The resulting crystals (Fig. 2B), well formed half-hexagonal plates, 0.3-mm in the longest dimension, set the stage for future x-ray structure diffraction studies.

Cloning the Catalytic and Pseudo-DHO Subunits-- The pseudo-DHO coding sequence was deleted from pJV34 by restriction with AspI and HindIII and religation. Transformation of the resulting construct, pJV30, into BL21 cells, resulted in the expression of high levels of the P. aeruginosa catalytic chain. However, all of the protein was present in insoluble inclusion bodies and exhibited no catalytic activity. The insoluble protein was dissolved in 8 M urea and then dialyzed against 50 mM Tris-HCl, pH 8.5, 10% glycerol. The protein remained in solution after removal of the denaturant, suggesting that it had refolded into a stable, soluble species, but the enzymatic activity was not recovered.

In another series of experiments, the catalytic chain coding sequence in pJV34 was deleted by digestion with XhoI and HindIII. High levels of the isolated pDHO subunit were expressed when the truncated plasmid was transformed into BL21(DE3) cells.2 This species was completely soluble but, as expected, had no catalytic activity.

In an attempt to reconstitute the native complex, 70 ng of the refolded catalytic subunit was titrated with increasing amounts (8-160 ng) of the soluble pDHO subunit (data not shown). Because only the catalytic chain carried the His tag affinity label, coelution of the 36- and 45-kDa subunits from the Ni2+ affinity column indicated that a stable complex was formed. However, the reconstituted complex also lacked catalytic activity.

The holoenzyme was incubated in various concentrations of urea (0.2-2 M), and the chromatographed on the Ni2+ column equilibrated with the same concentration of urea. The enzyme dissociated by 2 M urea, as indicated by the elution of the 45-kDa pDHO subunits and retention of the 36-kDa catalytic chains on the column, but the catalytic activity was lost. Collectively, these results suggest that the isolated catalytic subunit must be associated with pDHO subunits to be catalytically active.

When ATCase was completely denatured in 8 M urea and then refolded by dialysis against a buffer lacking the denaturant, a complex consisting of stoichiometric amounts of the two ATCase subunits was recovered from the affinity column (Fig. 3A), but it was also inactive. Gel filtration chromatography (Fig. 3B) showed that the molecular mass of the reconstituted complex was similar to that of the native dodecamer (480 kDa), although the peak was broader, possibly an indication of the presence of higher and lower oligomers. Thus, although dissociated and denatured ATCase can be reconstituted into a complex resembling the native enzyme in size and subunit composition, it has not been possible to restore catalytic activity.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 3.   Reconstitution of urea-denatured ATCase. A, P. aeruginosa ATCase (500 µg in 1 ml), dissociated and denatured as described in the text, was refolded by dialysis against two changes of 0.05 M Tris-HCl, pH 8.5, 10% glycerol. The protein was fractionated on a Ni2+ affinity column as described in the legend to Fig. 2 and analyzed by SDS-gel electrophoresis. Both subunits were retained on the column with only small amounts eluting in the flow-through and wash fractions (lanes 2-5). Both subunits were eluted with 200 mM imidazole in the same buffer (lane 6) with a stoichiometry that closely resembled that of the native protein (lane 1). B, native P. aeruginosa ATCase was chromatographed on a Sepharose 6 column equilibrated with 0.05 M Tris-HCl, pH 8.5, 10% glycerol and eluted with the same buffer at a flow rate of 1 ml/min. The elution profile of the native protein (dashed line) was obtained by measuring the absorbance at 280 nm. A second sample of the enzyme (1 mg/0.5 ml) was denatured in 8 M urea for 12 h and then refolded by dialysis two times against 0.05 M Tris-HCl, pH 8.5, 10% glycerol. A sample of 0.44 mg of the refolded protein (solid line) was chromatographed on the same Superose 6 column as described for the native enzyme. The column profile (dash dotted lines) of two proteins derived from an invertebrate hemoglobin (a gift of S. Vinogradov) is also shown for comparison.

Steady State Kinetics-- The aspartate saturation curve of P. aeruginosa ATCase (Fig. 4A) was hyperbolic. As observed for the isolated E. coli ATCase catalytic subunit, there was no indication of cooperative substrate binding, but high concentrations of aspartate partially inhibited the enzyme (not shown). A least squares fit of the data gave a Km for aspartate of 2.6 mM and a Vmax, of 12,500 µmol/h/mg (Table II). The carbamoyl phosphate saturation curve (Fig. 4B) was also hyperbolic, but in this case there was no apparent substrate inhibition. The Km for carbamoyl phosphate was 0.49 mM. The pH optimum for catalysis was measured using saturating concentrations of aspartate and carbamoyl phosphate. Catalytic activity increased steeply as the pH increased from pH 7 to 8.5 and then began to decrease. A fit of the plot of ln(Vmax) against pH (not shown) to the Dixon equation gave a pKa of 8.1 for the acidic limb of the curve. The pH-rate profile of the P. aeruginosa enzyme closely resembles that of the E. coli ATCase catalytic subunit but is very different from bimodal pH dependence of the allosteric E. coli holoenzyme (39).


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 4.   Substrate saturation curves for P. aeruginosa ATCase. A, the ATCase activity was measured with aspartate as the variable substrate and carbamoyl phosphate fixed at 5 mM in the absence of nucleotide triphosphates (open circle ) and in the presence of 2 µM (), 4 µM (), and 6 µM (black-square) ATP. B, the ATCase activity was measured with carbamoyl phosphate as the variable substrate and aspartate fixed at 20 mM. For two of the curves, the assay was initiated with aspartate in the absence of nucleotides (open circle ) and the presence of 6 µM ATP (). For the other two curves, the assay was initiated with carbamoyl phosphate without ATP () and in the presence of 6 µM ATP (black-square).

                              
View this table:
[in this window]
[in a new window]
 
Table II
Steady state kinetic parameters of P. aeruginosa ATCase

Nucleotide Inhibition-- As reported previously (22, 23), P. aeruginosa ATCase was strongly inhibited by CTP, UTP, ATP, and GTP (Fig. 5A) but not the corresponding nucleotide monophosphates or nucleotide diphosphates (not shown). Measurement of the residual ATCase activity as the concentration of the nucleotide triphosphates was varied (Fig. 5B) showed the enzyme was inhibited 50% at nucleotide concentrations of about 2 µM and that all of the nucleotide triphosphates bound to the enzyme with approximately equal affinity. The apparent dissociation constant was 4 µM, a value far below the reported concentration of all of these nucleotides (40) in the P. aeruginosa cells.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 5.   The effect of nucleotides on the ATCase activity. A, the effect of nucleotide mono- and triphosphates at a concentration of 1 mM on the catalytic activity of P. aeruginosa ATCase assayed in the presence of 5 mM carbamoyl phosphate and 20 mM aspartate in 50 mM Tris-HCl, pH 8.5. B, the residual ATCase activity was measured using the conditions in A in the presence of a variable concentration of ATP (), CTP (open circle ), UTP (black-square), and GTP ().

The approach devised by Webb (34) was adopted to determine whether the ATCase inhibition produced by combinations of two nucleotides is additive, antagonistic, or synergistic. In this method, one inhibitor is held constant, whereas the other is varied over its effective range. In one series of experiments, the ATP concentration was held at 1 µM, whereas the UTP concentration ranged from 1 to 10 µM. Alternatively, the UTP concentration was held constant at 1 µM, whereas the ATP was varied from 1 to 10 µM. In both experiments at all concentrations, the observed fractional inhibition in the presence of both inhibitors (i12) was always less than that predicted from the fractional inhibition i1 and i2 of the individual inhibitors acting independently (i.e. i12 i1 + i2 - i1i2). This result, indicative of antagonistic inhibition (34), would be obtained if both nucleotides bind to the same site on the enzyme.

Effect of Nucleotide on the Steady State Kinetics-- Nucleotide triphosphates dramatically altered the steady state kinetics. In the presence of 2 µM ATP, the aspartate saturation curve (Fig. 4A) became strongly sigmoidal. The concentration of aspartate required for half-saturation, [S]0.5, increased from 2.6 to 14.0 mM, and the effects were even more pronounced at 4 and 6 µM ATP. ATP had little effect on Vmax. These curves were fit to the Hill equation and gave Hill coefficients (Table II) that ranged from 7.5 to 10.

Titration with the bisubstrate analog, N-phosphonacetyl-L-asparate (PALA), was used to determine whether the enzyme exhibits true cooperative substrate binding. When the E. coli holoenzyme is assayed using subsaturating concentrations of aspartate and carbamoyl phosphate, PALA appreciably activates (10-20-fold) at low concentrations and then inhibits the enzyme as the concentration of PALA approaches saturation. This unusual response has been interpreted (41) to be a consequence of the T to R transition that the enzyme undergoes upon substrate binding. The binding of PALA to one site on the enzyme is sufficient to shift the equilibrium to the high affinity, active R state, whereas the activity is lost as PALA binds to the remaining active sites on the enzyme. Initial activation followed by inhibition by carbamoyl phosphate analog, phosphonoacetate, was also observed for the E. coli enzyme.

However, in assays (not shown) conducted using 5 mM carbamoyl phosphate and 1 mM aspartate, the P. aeruginosa enzyme was inhibited at all concentrations of PALA. Similarly, phosphonoacetate inhibited at all concentrations tested when the assay contained 20 mM aspartate and 40 µM, carbamoyl phosphate. Neither compound activated the P. aeruginosa ATCase, a result consistent with the hyperbolic saturation curves observed in the absence of nucleotides.

In contrast, when 2 µM ATP was present, the response to PALA (Fig. 6) was found to be qualitatively similar to that exhibited by the native E. coli enzyme. The activity increased with increasing inhibitor concentrations up to a peak corresponding to a 2.4-fold activation at 1 nM PALA. The activity then began to decrease with increasing PALA concentration. These results indicated that the sigmoidal saturation kinetics observed in the presence of ATP can be attributed in part to cooperative interactions between the catalytic sites. However, the PALA activation was much less than that observed for E. coli ATCase despite the very high Hill coefficients (Table II), suggesting that other factors are involved. As discussed below, conformational changes induced by nucleotide binding are only slowly reversed. This hysteretic phenomenon is likely to be primarily responsible for the sigmoidal aspartate saturation curves.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 6.   The effect of PALA on the activity of P. aeruginosa ATCase. The ATCase was assayed using 5 mM carbamoyl phosphate and either 8 () or 12 mM (open circle ) aspartate and a variable concentration of the bisubstrate inhibitor, PALA, in the presence of 2 µM ATP. In the absence of ATP, PALA inhibited the enzyme at all concentrations (data not shown).

Order of Addition of Substrates and Effectors-- Unexpectedly, ATP had no effect on the carbamoyl phosphate saturation curves (Fig. 4B). The carbamoyl phosphate concentration in the assays for the aspartate saturation curve was 5 mM, whereas the aspartate concentrations used for the carbamoyl phosphate saturation curve was 20 mM. At the common point in these two plots (Fig. 4, A and B), 20 mM aspartate and 5 mM carbamoyl phosphate, the velocity was very different although the composition of the assay mixture was identical. The only difference between the assays for these two experiments was the order of addition of the substrate. The aspartate and carbamoyl phosphate saturation curves were initiated by the addition of carbamoyl phosphate and aspartate, respectively, to the complete assay mixture. ATP did not inhibit the enzyme when the assays for the carbamoyl phosphate saturation curve (Fig. 4B) were initiated by the addition of aspartate. If, instead, the carbamoyl phosphate assays were initiated with carbamoyl phosphate (Fig. 4B), the saturation curve in the absence of nucleotides was found to be superimposable on the curve obtained when the reaction was initiated with aspartate, but the activity is inhibited by 6 µM ATP to the same extent as that observed in the aspartate saturation curve.

To assess further whether the order of addition altered the observed activity, a series of assays were conducted in which the enzyme, substrates, and effectors were mixed in different sequences. The results (Table III) indicate that ATP is a potent inhibitor only when mixed with the enzyme in the absence of carbamoyl phosphate, regardless of whether the reaction is initiated with aspartate or carbamoyl phosphate. If carbamoyl phosphate and enzyme are first mixed, ATP does not inhibit the reaction. If both carbamoyl phosphate and ATP were present when the enzyme was added to the assay mixture, the observed catalytic activity was the same as that observed in the absence of the nucleotide, indicating that enzyme binds carbamoyl phosphate preferentially. The effect of ATP is not a consequence of its reaction with the enzyme or with any of the substrates because the non-hydrolyzable ATP analog, AMP-PNP, exhibited identical effects on the activity of the enzyme.

                              
View this table:
[in this window]
[in a new window]
 
Table III
Effect of order of addition of substrates and nucleotides
The components of the assay mixture were added to a final concentration of 0.05 µg/ml P. aeruginosa ATCase, 20 mM aspartate, 5 mM carbamoyl phosphate, and 6 µATP.

Effect of Magnesium-- Excess MgCl2 abolished the inhibition of P. aeruginosa ATCase by ATP. In the absence of nucleotide, Mg2+ ion alone in concentrations ranging from 1 µM to 1 mM had no effect on the catalytic activity (data not shown). However, if ATP and Mg2+ were present in equimolar concentrations, ATP no longer altered the activity of the enzyme. This result suggested that ATP but not the MgATP complex was responsible for inhibition. To test this interpretation, the activity of the enzyme was measured in the presence of 2 µM ATP and increasing concentrations of MgCl2. A plot of the residual enzyme activity (Fig. 7) showed that inhibition closely paralleled the concentration of free ATP calculated from the concentration of ATP and Mg2+ in the assay mixture.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 7.   The effect of Mg2+ on ATP inhibition of P. aeruginosa ATCase. The ATCase activity () was assayed as described under "Experimental Procedures" in the presence of 6 µM ATP and a variable concentration of MgCl2. The concentration of free ATP (open circle ) was calculated from the total concentration of ATP and the MgCl2 concentration as described by Perrin and Sharma (36). High concentration of MgCl2 partially inhibited the activity of the enzyme, so the dotted line was calculated using the Vmax obtained in the absence of ATP and MgCl2. The crossover point of the two curves corresponds to 50% inhibition and 50% free ATP suggesting that only free ATP inhibits the enzyme.

Binding of an ATP Analog-- The binding of ATP fluorescent analog, 1,N6-ethenoadenosine 5'-triphosphate (epsilon ATP), to P. aeruginosa ATCase was measured by fluorescence spectroscopy. The fluorescence intensity increased with increasing concentrations of epsilon ATP added to the enzyme and exhibited normal saturation kinetics (not shown). The dissociation constant for the epsilon ATP-ATCase complex was 4 µM, close to the value obtained from the ATP inhibition kinetics indicating that ATP and epsilon ATP bind to the enzyme with comparable affinity. In the absence of Mg2+, epsilon ATP inhibited the enzyme activity to the same extent when assays were initiated by the additional of carbamoyl phosphate. The addition of MgCl2 to epsilon ATP-ATCase (Fig. 8) reversed the increase in fluorescence suggesting Mg2+ displaced bound epsilon ATP and that the Mg2+ complex, like MgATP, does not bind to the enzyme. The fluorescence change was completely reversed as the concentration of MgCl2 approached 30 µM, the concentration of epsilon ATP in the reaction mixture. Similarly, ATP displaced the bound fluorescent analog, although in this case the curve is distinctly sigmoidal reflecting the difficulty of dislodging epsilon ATP from the enzyme. The addition of carbamoyl phosphate to the epsilon ATP-ATCase complex did not entirely displace the bound analog judging from the small change in the fluorescence intensity observed over a range of carbamoyl phosphate of 0-5000 µM. However, the preincubation of the enzyme with carbamoyl phosphate reduced subsequent binding of the ATP analog.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 8.   The binding of epsilon ATP to P. aeruginosa ATCase. The fluorescence of a mixture of 30 µM epsilon ATP and 6.2 µM of purified P. aeruginosa ATCase was measured using an excitation wavelength of 300 nm and an emission wavelength of 408 nm. The decrease in fluorescence was measured with increasing carbamoyl phosphate (), MgCl2 (open circle ), or ATP () concentration.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

P. aeruginosa ATCase is a representative of the class A aspartate transcarbamoylase first identified by Jones and colleagues (22). The class B and C ATCases have been well characterized, but progress on the class C enzymes has been hampered by the lack of adequate amounts of the purified protein. The level of expression of the protein in P. aeruginosa cells is low, and the purification procedure involves many steps, and the protein is relatively unstable so that the purified enzyme has low specific enzyme activity. We report here the cloning and overexpression of P. aeruginosa enzyme. The enzyme carries a His tag appended to the amino end of the catalytic subunit that allows the homogeneous protein to be recovered in a single step on a Ni2+ affinity column. The observation that the purified enzyme had a specific activity that was 51-fold higher than the protein isolated from pA10 transformants and 11-fold higher that the protein directly purified (23) from P. fluorescens cells underscores the efficacy of a rapid isolation procedure.

The complete conservation in P. aeruginosa ATCase of all of the residues implicated in catalysis in the E. coli ATCase catalytic subunit, as well as an identical pH dependence, suggests that the two enzymes share a common catalytic mechanism. E. coli ATCase, a class B enzyme, can be dissociated by mercurials into two enzymatically active trimers and three regulatory dimers. Structural studies subsequently showed that all of the residues required for substrate binding and catalysis are present within the catalytic chain and that the active site is a composite composed of residues on two adjacent catalytic chains within the trimer. The class C ATCase from B. subtilis (19) and the isolated ATCase domain of the mammalian multifunctional protein CAD (42, 43) are catalytically active trimers. Thus, in these enzymes, the trimer is necessary and sufficient for catalysis.

In contrast, previous attempts (25) to express Pseudomonas catalytic subunits by deletion of the pDHO gene (pyrC') yielded plasmids that, unlike the parental constructs, were unable to complement E. coli strains deficient in ATCase. This observation led to the suggestion that, unlike the catalytic subunit of E. coli ATCase and the class C enzymes, the P. aeruginosa catalytic subunit is inactive in the absence of the pDHO chains. Similarly in this study, deletion of the pyrC' gene in the pJV30 construct led to the expression of large amounts of catalytic subunit, but all of the protein was found in inclusion bodies and was inactive. This result suggested that the catalytic subunit cannot fold properly in the absence of the pDHO subunit but did not directly address the question as to whether the isolated catalytic subunit, once folded, required the pDHO subunit for activity. The insoluble protein was solubilized in 8 M urea and refolded into soluble trimers but did not recover catalytic activity. The addition of the pDHO polypeptide to the refolded catalytic trimer resulted in the formation of a stable complex but did not restore catalytic activity. These results suggest that in the absence the catalytic chains are unable to assume the tertiary structure required for activity. This conclusion remains tentative as it is possible that conditions could be found that result in proper folding of the isolated catalytic subunit in catalytically active form, but nevertheless it is true that coexpression of the two subunits facilitates the formation of native complex.

P. aeruginosa ATCase is exquisitely sensitive to micromolar concentration of all the nucleotide triphosphates. The intracellular concentrations of ATP, CTP, UTP, and GTP have been found (40) to be 4.4, 0.8, 2.1, and 3.0 mM respectively, in P. putida cells, so it is difficult to imagine circumstances under which ATCase can be catalytically active. The regulatory logic of the system was also puzzling. Inhibition by purine nucleotides, as well as pyrimidine nucleotides, while not unprecedented, is difficult to rationalize. In E. coli ATCase, for example, ATP is an allosteric activator that signals the availability of purine nucleotides and coordinates the flux through the pyrimidine and purine pathways. Also the Hill coefficients of the P. aeruginosa enzyme measured in the presence of ATP are much higher than those of E. coli ATCase. The observation that PALA activates the enzyme at low concentration confirms that weak cooperative transitions between active sites do occur, but these alone cannot account for the strongly sigmoidal saturation curves.

The unusual kinetics can be explained by two additional observations. First, the inhibition is abolished by Mg2+ and the extent of inhibition exhibits a convincing inverse correlation with the concentration of the MgATP complex. Thus, it is likely that only free ATP can bind to the enzyme. Neither the total magnesium ion concentration nor the concentration of free nucleotide triphosphates in the cell are known. However, it is possible that these nucleotides exist primarily as the Mg2+ complex, in which case inhibition of ATCase inhibition would be attenuated. Thus, the Mg2+ effectively buffers the nucleotides and the activity of the enzyme in vivo probably depends on the precise balance of free nucleotides and their metal ion complexes.

Second, the inhibition is observed only when the reaction is initiated with carbamoyl phosphate. No inhibition is observed if the enzyme is first preincubated with this substrate, a result that suggests that the nucleotides may bind near the active site. In support of this interpretation, chemical modification with the ATP analog, FSBA, showed (23) that the nucleotides bind to the catalytic subunit. Moreover, deletion mutants lacking the first 34 residues at the amino end of the P. putida catalytic chain have been found (25) to be insensitive to nucleotides, indicating that this region of the molecule participates in feedback inhibition. Much of this chain segment may well be important, although 8 of these residues have been substituted in the construct described here, with the complete retention of nucleotide sensitivity. The lack of discrimination between nucleotide bases and the failure of mono- and diphosphate nucleotide to inhibit the enzyme might suggest that the gamma -phosphate moiety of the triphosphates may compete with carbamoyl phosphate in binding at the active site. Nucleotide triphosphates, pyrophosphate, and other phosphate compounds have been shown to be competitive inhibitors of carbamoyl phosphate binding to the E. coli enzyme. However, the observation that the inhibition constants are in the micromolar range, not in the millimolar range as observed for the E. coli enzyme (44), and that ATP inhibition is non-competitive, not competitive, with respect to carbamoyl phosphate argues against this interpretation. Thus, it is likely that there is a high affinity nucleotide-binding site on the catalytic chain distinct from the active site.

The interaction of ATP with the enzyme was investigated in steady state kinetic studies and binding studies using epsilon ATP, a fluorescent analog that binds with comparable affinity and elicits the same inactivation as ATP. Once bound the nucleotide triphosphate is tightly associated with the enzyme and is not in rapid equilibrium with carbamoyl phosphate. As the nucleotide is slowly displaced from the enzyme by high concentration of carbamoyl phosphate, the activity is gradually restored. This explanation accounts for the extreme sigmoidicity of the aspartate saturation curves. Conversely, when carbamoyl phosphate is bound to the enzyme, the nucleotide binds weakly and cannot inhibit the enzyme. The on constant for the association of nucleotides with the enzyme, as well as the off constant, must be slow, because when both the nucleotide and carbamoyl phosphate are simultaneously present, the nucleotide does not inhibit the enzyme.

Many eubacteria, including P. aeruginosa, have a single CPSase (46) that provides carbamoyl phosphate for both pyrimidine and arginine biosynthesis. In addition (47), P. aeruginosa has an arginine deiminase pathway (Fig. 9) that allows the organism to use arginine as an energy source. The latter pathway is considered to be particularly important during anaerobic growth (48). Carbamoyl phosphate, produced by the concerted action of arginine deiminase and catabolic ornithine decarboxylase, is converted to ATP, CO2, and NH<UP><SUB>4</SUB><SUP>+</SUP></UP> by carbamate kinase. Thus, there are two routes to carbamoyl phosphate synthesis and three fates for the intermediate once formed. Consequently, the regulation of carbamoyl phosphate is complex and not well understood. When the cells grow in a medium rich in nucleotides and a plentiful source of energy-producing metabolites, the intracellular concentration of NTPs is high. It may be that inhibition of ATCase occurs if the concentration of free NTPs exceeds that of available Mg2+, thus blocking further de novo synthesis of pyrimidines. The elevated ATP levels also inhibit two enzymes of the arginine deiminase pathway (46, 47). It is interesting that Mg2+ ion activates arginine deaminase by decreasing the Km value for arginine 12-fold (49); thus limiting Mg2+ when NTPs are abundant would down-regulate the arginine deiminase pathway as well as the pyrimidine biosynthesis. Arginine biosynthesis can proceed unless the level of citrulline is too low to sustain further arginine synthesis and activate CPSase. When the energy charge is low, inhibition of the arginine deiminase pathway is relieved allowing the organism to extract energy from arginine catabolism. Partial UMP inhibition of CPSase and limiting ATP would be expected to decrease the synthesis of carbamoyl phosphate for pyrimidine biosynthesis. However, carbamoyl phosphate is also an intermediate in the arginine deiminase pathway and in principle might be expected to enter the pyrimidine pathway especially because the Km value for carbamoyl phosphate of ATCase (0.4 mM) reported here is 6-fold lower than that of carbamate kinase (5 mM at 2 mM ADP) (9). This crossover apparently does not occur in the cell because carB mutants, deficient in CPSase, require uracil for growth (50). This observation suggests that the carbamoyl phosphate produced by arginine catabolism is unavailable for pyrimidine biosynthesis. Thus, there must be other as yet undiscovered mechanisms that control carbamoyl phosphate entry into the pyrimidine and arginine biosynthetic pathways or sequester the intermediate formed by the arginine deiminase pathway.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 9.   Carbamoyl phosphate metabolism in P. aeruginosa. The enzymes involved in carbamoyl phosphate formation and utilization include carbamoyl phosphate synthetase (CPSase), aspartate transcarbamoylase (ATCase), anabolic ornithine transcarbamoylase (OTCase), and the enzymes of the arginine deiminase pathway, arginine deiminase (ADase), catabolic ornithine transcarbamoylase (cOTCase), and carbamate kinase (CKase). The allosteric regulation of these enzymes by inhibitors (-) and activators (+) is represented by dotted lines.

In summary, using the construct described here, P. aeruginosa ATCase can be rapidly purified to homogeneity in quantities that make possible, for the first time, structure-function studies of any class A ATCase. The pDHO subunit is needed for optimal folding of the ATCase and perhaps to stabilize the optimal conformation once the enzyme has folded. Kinetic studies demonstrated that free nucleotides, but not the Mg2+ complex, bind to the enzyme and that carbamoyl phosphate antagonizes nucleotide binding. These observations provide an explanation for the unusual inhibition by a low concentrations of a broad range of nucleotide triphosphates, although the physiological role remains to be established. However, the effect of metabolites on the catalytic activity of Pseudomonas ATCase is distinctly different from that reported for ATCase from other prokaryotic and all eukaryotic organisms, and thus this enzyme may represent a potential target for drug design. For example, a cell-permeable nucleotide analog that inhibits P. aeruginosa ATCase in the presence of Mg2+ would be expected to abolish selectively pyrimidine biosynthesis in the microorganism.

    ACKNOWLEDGEMENTS

We thank Dr. Askar Kuchumov and Dr. Serge Vinogradov for help and advice on the fast protein liquid chromatography studies.

    FOOTNOTES

* This work was supported by National Science Foundation Grant MCB-9810325, National Science Foundation Postdoctoral Fellowship INT9203314, and National Institutes of Health Grant GM47399.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) L19649.

To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, Wayne State University School of Medicine, 540 E. Canfield Ave., Detroit, MI 48201. Tel.: 313-577-1016; Fax: 313-577-2765; E-mail: devans@cmb.biosci.wayne.edu.

Published, JBC Papers in Press, April 16, 2002, DOI 10.1074/jbc.M200009200

2 N. Sahay, unpublished data.

    ABBREVIATIONS

The abbreviations used are: ATCase, aspartate transcarbamoylase; epsilon ATP, 1,N6-ethenoadenosine 5'-triphosphate: pDHO, pseudo-dihydroorotase, an inactive homolog of dihydroorotase; AMP-PNP, 5'-adenylylimidodiphosphate; MES, 4-morpholineethanesulfonic acid; PALA, N-phosphonoacetyl-L-aspartate; CPSase, carbamoyl phosphate synthetase; FSBA, 5'-p-fluorosulfonylbenzoyladenosine.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Palmer, D., and Bender, C. (1993) Appl. Environ. Microbiol. 59, 1619-1626[Abstract/Free Full Text]
2. Zhang, Y., Rowley, K., and Patil, S. (1993) J. Bacteriol. 175, 6451-6458[Abstract/Free Full Text]
3. Preston, M., Kernack, K., and Berk, R. (1993) Infect. Immun. 61, 2713-2716[Abstract/Free Full Text]
4. Hobden, J., Hill, J., Engel, L., and Ocallaghan, R. (1993) Antimicrob. Agents 37, 1856-1859
5. Tredget, E., Shankowsky, H., Joffe, A., Inkson, T., Volpel, K., Paranchych, W., Kibsey, P., Alton, J., and Burke, J. (1992) Clin. Infect. Dis. 15, 941-949[Medline] [Order article via Infotrieve]
6. Xu, G., and West, T. (1992) J. Gen. Microbiol. 138, 2459-2463
7. Condon, S., Collins, J., and O'Donovan, G. (1976) J. Gen. Microbiol. 92, 375-383[Abstract/Free Full Text]
8. Isaac, J., and Holloway, B. (1968) J. Bacteriol. 96, 1732-1741[Abstract/Free Full Text]
9. Abdelal, A. T., Bibb, W. F., and Nainan, O. (1982) J. Bacteriol. 151, 1411-1419[Abstract/Free Full Text]
10. Abdelal, A., Bussey, L., and Vickers, L. (1983) Eur. J. Biochem. 129, 697-702[Medline] [Order article via Infotrieve]
11. Jones, M., Spector, L., and Lipmann, F. (1955) J. Am. Chem. Soc. 77, 819-820[CrossRef]
12. Prescott, L. M., and Jones, M. E. (1969) Anal. Biochem. 32, 408-419[CrossRef][Medline] [Order article via Infotrieve]
13. Honzatko, R. B., Crawford, J. L., Monaco, H. L., Ladner, J. E., Ewards, B. F., Evans, D. R., Warren, S. G., Wiley, D. C., Ladner, R. C., and Lipscomb, W. N. (1982) J. Mol. Biol. 160, 219-263[CrossRef][Medline] [Order article via Infotrieve]
14. Ke, H. M., Honzatko, R. B., and Lipscomb, W. N. (1984) Proc. Natl. Acad. Sci. U. S. A. 81, 4037-4040[Abstract/Free Full Text]
15. Krause, K. L., Volz, K. W., and Lipscomb, W. N. (1987) J. Mol. Biol. 193, 527-553[CrossRef][Medline] [Order article via Infotrieve]
16. Lipscomb, W. N. (1994) Adv. Enzymol. Relat. Areas Mol. Biol. 68, 67-151[Medline] [Order article via Infotrieve]
17. Wild, J. R., and Wales, M. E. (1990) Annu. Rev. Microbiol. 44, 193-218[CrossRef][Medline] [Order article via Infotrieve]
18. Purcarea, C., Herve, G., Ladjimi, M. M., and Cunin, R. (1997) J. Bacteriol. 179, 4143-4157[Abstract/Free Full Text]
19. Barbson, J. S., and Switzer, R. L. (1975) J. Biol. Chem. 250, 8664-8669[Abstract/Free Full Text]
20. Lerner, C. G., and Switzer, R. L. (1986) J. Biol. Chem. 261, 11156-11165[Abstract/Free Full Text]
21. Stevens, R. C., Reinisch, K. M., and Lipscomb, W. N. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 6087-6091[Abstract/Free Full Text]
22. Adair, L. B., and Jones, M. E. (1972) J. Biol. Chem. 247, 2308-2315[Abstract/Free Full Text]
23. Bergh, S. T., and Evans, D. R. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 9818-9822[Abstract/Free Full Text]
24. Shepherdson, M., and McPhail, D. (1993) FEMS Microbiol. Lett. 114, 201-206[CrossRef][Medline] [Order article via Infotrieve]
25. Schurr, M. J., Vickrey, J. F., Kumar, A. P., Campbell, A. L., Cunin, R., Benjamin, R. C., Shanley, M. S., and O'Donovan, G. A. (1995) J. Bacteriol. 177, 1751-1759[Abstract/Free Full Text]
26. Souciet, J.-L., Nagy, M., Legouar, M., Lacroute, F., and Potier, S. (1989) Gene (Amst.) 79, 59-70[CrossRef][Medline] [Order article via Infotrieve]
27. Wales, M. E., Madison, L. L., Glaser, S. S., and Wild, J. R. (1999) J. Mol. Biol. 294, 1387-1400[CrossRef][Medline] [Order article via Infotrieve]
28. Nowlan, S. F., and Kantrowitz, E. R. (1985) J. Biol. Chem. 260, 14712-14716[Abstract/Free Full Text]
29. Maniatis, T., Fritsch, E. R., and Sambrook, I. (1982) Molecular Cloning: A Laboratory Manual , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
30. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951) J. Biol. Chem. 193, 265-275[Free Full Text]
31. Laemmli, U. K. (1970) Nature 227, 680-685[CrossRef][Medline] [Order article via Infotrieve]
32. Pastra-Landis, S. C., Foote, J., and Kantrowitz, E. R. (1981) Anal. Biochem. 118, 358-363[CrossRef][Medline] [Order article via Infotrieve]
33. Perbal, B., and Herve, G. (1972) J. Mol. Biol. 70, 511-529[CrossRef][Medline] [Order article via Infotrieve]
34. Webb, J. (1963) Enzyme and Metabolic Inhibitors , Vol. 1 , pp. 507-510, Academic Press, New York
35. Leger, D., and Herve, G. (1988) Biochemistry 27, 4293-4298[CrossRef]
36. Perrin, D. D., and Sharma, V. S. (1966) Biochim. Biophys. Acta 127, 35-41[Medline] [Order article via Infotrieve]
37. Huff, J. P., Grant, B. J., Penning, C. A., and Sullivan, K. F. (1990) BioTechniques 9, 570-577
38. Jancarik, J., and Kim, S.-H. (1991) J. Appl. Crystallogr. 24, 409-411[CrossRef]
39. Weitzman, P. D. J., and Wilson, I. B. (1966) J. Biol. Chem. 241, 5481-5488[Abstract/Free Full Text]
40. Dutta, O., and O'Donovan, G. (1987) J. Chromatogr. 385, 119-124[CrossRef][Medline] [Order article via Infotrieve]
41. Foote, J., and Schachman, H. (1985) J. Mol. Biol. 186, 175-184[CrossRef][Medline] [Order article via Infotrieve]
42. Grayson, D. R., and Evans, D. R. (1983) J. Biol. Chem. 258, 4123-4129[Abstract/Free Full Text]
43. Maley, J. A., and Davidson, J. N. (1988) Mol. Gen. Genet. 213, 278-284[CrossRef][Medline] [Order article via Infotrieve]
44. Issaly, I., Poiret, M., Tauc, P., Thiry, L., and Hervé, G. (1982) Biochemistry 21, 1612-1623[CrossRef][Medline] [Order article via Infotrieve]
45. Vickrey, J. F. (1993) Isolation and Characterization of the Operon Containing Aspartate Transcarbamoylase and Dihydroorotase from Pseudomonas aeruginosa.Ph.D. thesis , University of North Texas, Denton, TX
46. Stalon, V., Ramos, F., Piérard, A., and Wiame, J. M. (1972) Eur. J. Biochem. 29, 25-35[Medline] [Order article via Infotrieve]
47. Mercenier, A., Simon, J. P., Vander Wauven, C., Haas, D., and Stalon, V. (1980) J. Bacteriol. 44, 159-163
48. Shoesmith, J. G., and Sherris, J. C. (1960) J. Gen. Microbiol. 22, 10-24[Abstract/Free Full Text]
49. Bauer, H., Luethi, E., Stalon, V., Mercenier, A., and Haas, D. (1989) Eur. J. Biochem 179, 53-60[Medline] [Order article via Infotrieve]
50. Haas, D., Holloway, B. W., Schambock, A., and Leisinger, T. (1977) Mol. Gen. Genet. 154, 7-22[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. Ahuja, C. Purcarea, R. Ebert, S. Sadecki, H. I. Guy, and D. R. Evans
Aquifex aeolicus Dihydroorotase: ASSOCIATION WITH ASPARTATE TRANSCARBAMOYLASE SWITCHES ON CATALYTIC ACTIVITY
J. Biol. Chem., December 17, 2004; 279(51): 53136 - 53144.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
V. Barbe, D. Vallenet, N. Fonknechten, A. Kreimeyer, S. Oztas, L. Labarre, S. Cruveiller, C. Robert, S. Duprat, P. Wincker, et al.
Unique features revealed by the genome sequence of Acinetobacter sp. ADP1, a versatile and naturally transformation competent bacterium
Nucleic Acids Res., October 28, 2004; 32(19): 5766 - 5779.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Purcarea, A. Ahuja, T. Lu, L. Kovari, H. I. Guy, and D. R. Evans
Aquifex aeolicus Aspartate Transcarbamoylase, an Enzyme Specialized for the Efficient Utilization of Unstable Carbamoyl Phosphate at Elevated Temperature
J. Biol. Chem., December 26, 2003; 278(52): 52924 - 52934.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/27/24490    most recent
M200009200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vickrey, J. F.
Right arrow Articles by Evans, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vickrey, J. F.
Right arrow Articles by Evans, D. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement